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ABSTRACT  
The regenerative mechanisms ascribed to mesenchymal stem cells (MSCs) are classified into 3 categories: 
differentiating into damaged cell types, supplying nutrients, and improving survival/functions of the endogenous 
cells via paracrine actions. However, because of the inhospitable microenvironment of the injured tissues, a 
proportion of the implanted MSCs may quickly die, suggesting that other mechanisms might be present. This 
notion is supported by the overlapping beneficial effect (in terms of time of healing) resulted  after the injection 
of AMCs or of amniotic mesenchymal cells - conditioned medium (AMC-CM)  in equine spontaneous injured 
tendons and ligaments. Microvesicles (MVs) released by cells are an integral component of the cell-to-cell 
communication network involved in tissue regeneration.In the present study, MVs secreted by AMCs were 
investigated with Nanosigth instrument and TEM. Then, the in vitro incorporation of MVs into equine tendon cells 
was studied by a dose-response curve. Lastly, the ability of MVs to counteract an in vitro inflammatory process 
induced by lipolysaccaride on tendon cells was studied evaluating the expression of pro-inflammatory genes like 
metallopeptidase (MPP) 1 and 13, and prostaglandin-endoperoxide synthase 2 (COX2). Results demonstrated that 
AMCs secreted MVs ranging in size from 100 to 1000 nm with a prevalence of 100-200 nm large MVs. Tendon cells 
were able to uptake them with an inverse relationship between concentration and time. The greatest 
incorporation was detectable at 40x106 MVs/ml after 72h. MVs induced down-regulation of MMP1 and MMP13, 
suggesting that they may have contributed, along with soluble factors, to in vivo tendon regeneration.  
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